 | Up a level |
Liu, Jinxia; MacNaughtan, Jane; Kerbert, Annarein J C; Portlock, Theo; Martínez Gonzalez, Javier; Jin, Yi; Clasen, Frederick; Habtesion, Abeba; Ji, Huoyan; Jin, Qin; Phillips, Alexandra; De Chiara, Francesco; Ingavle, Ganesh; Jimenez, Cesar; Zaccherini, Giacomo; Husi, Katherine; Rodriguez Gandia, Miguel Angel; Cordero, Paul; Soeda, Junpei; McConaghy, Lynda; ... (2024). Clinical, experimental and pathophysiological effects of Yaq-001: a non-absorbab le, gut-restricted adsorbent in models and patients with cirrhosis. Gut, 73(7), pp. 1183-1198. BMJ Publishing Group 10.1136/gutjnl-2023-330699
Rudler, Marika; Hernández-Gea, Virginia; Procopet, Bogdan Dumitru; Giráldez, Alvaro; Amitrano, Lucio; Villanueva, Càndid; Ibañez, Luis; Silva-Junior, Gilberto; Genesca, Joan; Bureau, Christophe; Trebicka, Jonel; Bañares, Rafael; Krag, Aleksander; Llop, Elba; Laleman, Wim; Palazon, Jose Maria; Castellote, Jose; Rodrigues, Susana; Gluud, Lise Lotte; Noronha Ferreira, Carlos; ... (2023). Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding. Gut, 72(4), pp. 749-758. BMJ Publishing Group 10.1136/gutjnl-2022-326975
